Details for Patent: 8,735,372
✉ Email this page to a colleague
Title: | Nucleoside phosphoramidate prodrugs |
Abstract: | Disclosed herein are phosphoramidate prodrugs of nucleoside derivatives for the treatment of viral infections in mammals, which is a compound, its stereoisomer, salt (acid or basic addition salt), hydrate, solvate, or crystalline form thereof, represented by the following structure: ##STR00001## Also disclosed are methods of treatment, uses, and processes for preparing each of which utilize the compound represented by formula I. |
Inventor(s): | Du; Jinfa (Redwood City, CA), Nagarathnam; Dhanapalan (Bethany, CT), Sofia; Michael Joseph (Doylestown, PA), Wang; Peiyuan (Totowa, NJ) |
Assignee: | Gilead Pharmasset LLC (Foster City, CA) |
Filing Date: | Oct 18, 2013 |
Application Number: | 14/057,675 |
Claims: | >Claims of U.S. Appl. No. 14/013,237 as amended Aug. 30, 2013. cited by applicant . U.S. Appl. No. 13/956,195, filed Jul. 31, 2013. cited by applicant . Claims of U.S. Appl. No. 13/956,195 as amended Oct. 21, 2013. cited by applicant. |
Primary Examiner: Lewis; Patrick
Attorney, Agent or Firm: